Value in Health – An HEOR Publication

📅 Don't forget to mark your calendar for the upcoming #ISPOREurope meeting in Glasgow! Monday afternoon's Value in Health Editorial Forum will be a panel not to miss! Join the Editors-in-Chief Nancy Devlin and C. Daniel Mullins, plus moderator Adrian Towse, in conversation with 3 authors of recent Value in Health papers. Note the updated presenter lineup now includes Peter Neumann along with Sean Sullivan and Paper of the Year awardee Yawen Jiang. #DrugPricing #HEOR

📣 Last week ISPOR announced its annual awards, including the inaugural ISPOR Impact Award. Value in Health was very excited to see 2 of our Associate Editors awarded this new award, Rachael Fleurence, Ph.D. and Jagpreet (Jag) Chhatwal! The ISPOR Impact Award recognizes the positive influence #HEOR professionals have in making #HighValueHealthcare (ie, patient-centric, value-based #healthcare) more accessible, effective, efficient, and affordable at the international, national, regional, health system, hospital, and/or individual care levels. For more info about the Impact Award and the details about why Rachael and Jag were awarded it, you can go here: https://lnkd.in/eHxa3QJ8

⭐ Editor's Choice: Comprehensive Access to #Semaglutide: Clinical and Economic Implications for #Medicare Medicare has yet to cover glucagon-like peptide 1 receptor agonists across the full range of FDA-approved indications. We sought to quantify the comprehensive clinical and economic impact of semaglutide in the Medicare population, considering not only obesity but also current and anticipated future indications. Our findings suggest that the potential clinical value of semaglutide in the Medicare population is substantial and comprehensive access to semaglutide would result in net savings of between $1.04 billion to $412 million over 10 years, with substantially higher savings when accounting for loss of exclusivity. #OpenAccess: https://lnkd.in/eeURrXT2 Authors: Victoria W. Dayer, PharmD | Iman Nourhussein | Adam Kasle | Ryan N. Hansen, PhD | Angelo N. | Sean Sullivan The CHOICE Institute | Curta | University of North Carolina at Chapel Hill Editors-in-Chief: Nancy Devlin | C. Daniel Mullins #GLP1 #obesity #diabetes

📣 ISPOR has awarded the annual Value in Health Paper of the Year Award for 2024 to Patient Welfare Implications of Indication-Specific Value-Based Pricing of Multi-Indication Drugs, from lead author Yawen Jiang. This award promotes quality research, originality, and utility in healthcare decisions for articles published in Value in Health. 💡 Highlights ➡️ Indication-specific value-based pricing (ISVBP) varies drug prices across users. ➡️ The patient welfare implications of ISVBP are not well documented by far. ➡️ Our theoretical results suggest that ISVBP is not necessarily patient welfare improving, and ISVBP should be carefully evaluated and implemented. 📖 https://lnkd.in/eMwgUzVy Authors Meng Li | Shan Jiang | Lei Si | Yuanyuan Gu Sun Yat-sen Univeristy | Center for the Evaluation of Value and Risk in Health (CEVR) | Macquarie University Centre for the Health Economy | Western Sydney University

Value in Health recognizes that our model of reviewing papers is literally impossible without the volunteer efforts of our peer reviewers. We know it takes time and effort to review a paper well. Providing good feedback to fellow researchers is a gift to those authors, one we hope is returned to the reviewers when they, in turn, submit papers to Value in Health. 📣 We are looking for more peer reviewers to help share the load of reviewing #HEOR material from all fields and around the globe. 📖 For more info on what Value in Health looks for in a reviewer, or to sign up as a volunteer reviewer, check this page: https://lnkd.in/eTcHensM

⭐ Editor's Choice: Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel This study included multiple phases across stakeholder groups to elicit consensus around the following patient-centered value and #HealthTechnologyAssessment themes: (1) patient and caregiver engagement, (2) economic evaluations and data inputs, (3) communicating findings, models, and quality, (4) importance of additional research on methods and data inputs, and (5) educational resource development priorities. The 28 consensus recommendations presented in this article serve as a basis for future work toward progressing #PatientCenteredValue and health technology assessment. Consensus on these recommendations indicates needed guidance for holistic approaches to value assessment. #OpenAccess: https://lnkd.in/ecw8Jibj Authors: Julia Slejko | Tara Lavelle | Joe Vandigo | Omar A. Escontrías, DrPH, MPH | Silke Schoch | Elisabeth Oehrlein, PhD, MS University of Maryland School of Pharmacy | Center for the Evaluation of Value and Risk in Health (CEVR) | Applied Patient Experience, LLC | National Health Council Editors-in-Chief: Nancy Devlin | C. Daniel Mullins #HTA #PatientCenteredCare

Proud to share our latest editorial in Value in Health – An HEOR Publication: “Methodological Challenges With Conducting Health Economic Evaluations in the Critical-Care Context.” 👉 https://lnkd.in/gTDVFFtA Critical care is one of the most resource-intensive and high-stakes areas in medicine. Yet despite its importance, health economic evaluations in intensive care units (ICUs) remain surprisingly rare and often methodologically inconsistent. In this piece, Stavros Petrou and I explore why conducting cost-effectiveness and value assessments in critical care is so difficult — and why getting it right matters for improving hospital efficiency and patient outcomes. We discuss: 💡 The massive heterogeneity among ICU patients that complicates study design 💡 The data gaps that make it hard to capture long-term outcomes or costs 💡 How better measurement and modeling can help hospitals eliminate “defects in value” and move toward zero waste in care delivery Even small methodological improvements can make a real dent in the trillion-dollar problem of wasteful care. I’m grateful to the ISPOR—The Professional Society for Health Economics and Outcomes Research Value in Health editorial team for highlighting this issue and to colleagues advancing economic evaluation in hospital medicine. Peter Pronovost MD, PhD, FCCM Patricia Davidson Mary Beth Makic USC Schaeffer Institute USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences #healtheconomics #valueinhealth #criticalcare #costeffectiveness #healthpolicy #hospitalquality

#ISPORNews Value in Health, the official journal of ISPOR, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. Learn more: https://ow.ly/VAiv50XaK4T

⭐ Editor's Choice: This systematic review takes an initial step toward defining opioid-free year (OfY) thresholds specific to #opioid use disorder interventions. US studies reported higher average incremental cost-effectiveness ratios for #OpioidUseDisorder interventions, ranging from $17,674 per OfY to $243,053 per OfY across 3 stakeholder perspectives, reflecting higher healthcare costs. In contrast, international studies showed incremental cost-effectiveness ratios ranging from $79,765 per OfY to $195,980 per OfY across stakeholder perspectives. These findings allow for comparison of economic evaluations and guide policy makers in making optimal decisions about resource allocation. This article is #OpenAccess, available here: https://lnkd.in/eZMqd93p Authors: BABASOJI OYEMAKINDE | Danielle Ryan | Techna Cadet | Tyler Judge | Manesh Gopaldas, MD, MS | Ali Jalali, PhD | Sean M. Murphy Weill Cornell Medicine | New York University | New York State Psychiatric Institute Editors-in-Chief: Nancy Devlin | C. Daniel Mullins